0% found this document useful (0 votes)
8 views19 pages

BLOOD VESSELS

Hypertensive vascular disease includes hypertension, classified as primary or secondary, with various causes and mechanisms. Atherosclerosis, a major concern, involves chronic inflammation of arteries leading to plaque formation and complications like aneurysms and dissections. Vasculitis, characterized by inflammation of blood vessels, can be classified by vessel size and includes conditions like giant cell arteritis and polyarteritis nodosa.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
8 views19 pages

BLOOD VESSELS

Hypertensive vascular disease includes hypertension, classified as primary or secondary, with various causes and mechanisms. Atherosclerosis, a major concern, involves chronic inflammation of arteries leading to plaque formation and complications like aneurysms and dissections. Vasculitis, characterized by inflammation of blood vessels, can be classified by vessel size and includes conditions like giant cell arteritis and polyarteritis nodosa.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 19

Hypertensive Vascular Disease

Definition

Hypertension (HTN) is a sustained elevation of diastolic pressure above 89 mm Hg or systolic


pressure above 139 mm Hg.

 Normal BP: <120/<80 mm Hg

 Prehypertension: 120–139 / 80–89 mm Hg

 Hypertension: ≥140 / ≥90 mm Hg

 Malignant hypertension: Rapidly rising BP (>200/120 mm Hg) → leads to end-organ


damage (especially kidneys, brain, eyes).

Classification of Hypertension

Type Description Prevalence

Primary (Essential) HTN No identifiable cause 90–95%

Secondary HTN Due to underlying disorder 5–10%

Causes of Secondary HTN

 Renal: Renal artery stenosis, chronic renal disease, polycystic kidney disease

 Endocrine: Cushing’s syndrome, Conn’s syndrome, pheochromocytoma,


hyperthyroidism

 Cardiovascular: Coarctation of the aorta

 Neurologic: Increased intracranial pressure

 Drugs: Oral contraceptives, NSAIDs

Mechanisms in Essential HTN

 Reduced renal sodium excretion (shift in pressure-natriuresis curve)

 Vasoconstrictive influences (↑ vasomotor tone)

 Genetic factors (e.g., polymorphisms in RAAS, ion transport genes)

 Environmental factors: Obesity, stress, salt intake, smoking, inactivity


Vascular Pathology in Hypertension

Two major morphologic types:

Type Description Seen in

Hyaline Homogeneous, pink hyaline thickening of arteriole walls Benign


Arteriolosclerosis with luminal narrowing HTN

“Onion-skin” concentric, laminated wall thickening with


Hyperplastic Severe
luminal narrowing (smooth muscle + basement membrane
Arteriolosclerosis HTN
reduplication)

Malignant HTN

 Fibrinoid necrosis of arterioles + necrotizing arteriolitis

 Acute kidney injury can occur

 Papilledema, encephalopathy, retinal hemorrhages

Arteriosclerosis

Definition

Arteriosclerosis = hardening of arteries


Includes 3 types:

1. Atherosclerosis (most important) – affects large and medium arteries

2. Arteriolosclerosis – affects small arteries and arterioles

3. Monckeberg Medial Calcific Sclerosis – calcification in media of muscular arteries;


usually incidental, not significant

Atherosclerosis

Definition

A progressive, chronic inflammatory disease of large/medium arteries marked by formation


of intimal atheromatous plaques.

Major Arteries Affected

 Elastic arteries: aorta, carotid, iliac

 Large muscular arteries: coronary, popliteal


Atherosclerotic Plaque Components

1. Fibrous cap: smooth muscle cells, ECM (collagen, elastin)

2. Necrotic core: lipid (cholesterol), debris, foam cells, fibrin

3. Neovascularization: small blood vessels at plaque base

Risk Factors for Atherosclerosis

Major Constitutional (Nonmodifiable)

 Age: 40–60 years and above → risk increases with age

 Sex: Men > women (premenopausal); risk equalizes postmenopause

 Genetics: Family history = strongest risk factor

Major Modifiable Risk Factors

 Hyperlipidemia (especially LDL↑, HDL↓)

 Hypertension

 Cigarette smoking

 Diabetes mellitus: Increases risk of MI by 2x

Other Risk Factors

 Inflammation (↑CRP)

 Hyperhomocysteinemia

 Metabolic syndrome

 Lipoprotein(a)

 Hemostatic factors (↑ fibrinogen)

 Sedentary lifestyle

Pathogenesis of Atherosclerosis

Key Concept: Chronic endothelial injury hypothesis

1. Endothelial injury/dysfunction

o Mechanical (shear stress), hyperlipidemia, smoking, immune


2. Accumulation of lipoproteins (especially oxidized LDL, cholesterol crystals)

3. Monocyte adhesion & transformation into foam cells

4. Inflammation – release of cytokines, growth factors

5. SMC migration & ECM deposition

6. Plaque progression – necrotic core, calcification, angiogenesis

Complications of Atherosclerotic Plaques

 Rupture → thrombosis

 Hemorrhage into plaque

 Aneurysm formation (due to media weakening)

 Embolism

 Calcification

Aneurysms and Dissection

Aneurysm: Definition

Localized abnormal dilation of a blood vessel or heart chamber

Type Morphology

Bounded by complete vessel wall; may be saccular or


True aneurysm
fusiform

False aneurysm Defect in wall → extravascular hematoma with fibrous


(pseudoaneurysm) capsule

Blood enters wall through tear and dissects between


Dissection
layers

Abdominal Aortic Aneurysm (AAA)

Common Site: Infrarenal abdominal aorta

Risk Factors

 Atherosclerosis (primary cause)

 Smoking
 Male gender

 Age >50

Complications

 Rupture → fatal hemorrhage

 Obstruction of branch vessels

 Embolism

 Compression of adjacent structures

Thoracic Aortic Aneurysm

Causes

 Hypertension (most common)

 Marfan syndrome (fibrillin-1 mutation)

 Syphilis (tertiary, rare now)

Symptoms

 Respiratory issues

 Dysphagia

 Persistent cough (recurrent laryngeal nerve compression)

 Aortic regurgitation

 Rupture

Aortic Dissection

Definition: Tear in intima → blood dissects between intima and media

Risk Factors

 Hypertension (90%)

 Connective tissue disorders: Marfan, Ehlers-Danlos

 Bicuspid aortic valve

Classification

 Stanford A: Involves ascending aorta ± descending (more common, dangerous)


 Stanford B: Descending aorta only

Complications

 Cardiac tamponade

 Aortic rupture

 End-organ ischemia

🩸 VASCULITIS

Inflammation of blood vessel walls leading to damage and potential ischemia

Classification of Vasculitis

Type Vessel Size Common Diseases

Large vessel Aorta and major branches Giant cell arteritis, Takayasu arteritis

Main visceral arteries &


Medium vessel Polyarteritis nodosa, Kawasaki disease
branches

Microscopic polyangiitis, GPA, Churg-


Small vessel Arterioles, capillaries, venules
Strauss

Noninfectious Vasculitis

Immune-mediated vessel injury, typically from immune complexes or autoantibodies.

Immune Complex–Associated Vasculitis

 Pathogenesis: Deposition of immune complexes activates complement → neutrophil


recruitment → vessel wall injury.

 Examples:

o Hypersensitivity vasculitis (drug or infection induced)

o Henoch-Schönlein purpura (IgA complexes)

o Cryoglobulinemic vasculitis

Antineutrophil Cytoplasmic Antibodies (ANCA)


Two main types:

 c-ANCA (cytoplasmic pattern): Directed against proteinase 3 (PR3); associated with


Granulomatosis with polyangiitis (GPA)

 p-ANCA (perinuclear pattern): Directed against myeloperoxidase (MPO); seen in


Microscopic polyangiitis and Churg-Strauss syndrome

Anti–Endothelial Cell Antibodies

 Found in some vasculitis cases; role unclear.

 Associated with Kawasaki disease and transplant vasculopathy.

Large Vessel Vasculitis

Giant Cell (Temporal) Arteritis

 Most common vasculitis in adults >50 years.

 Affects branches of the carotid artery, especially temporal artery.

 Pathogenesis: T-cell mediated granulomatous inflammation with multinucleated


giant cells.

 Clinical Features:

o Headache (temporal artery)

o Jaw claudication

o Visual loss (due to ophthalmic artery involvement)

o Elevated ESR

 Morphology:

o Intimal thickening → luminal narrowing

o Granulomatous inflammation of media

 Treatment: High-dose corticosteroids immediately (to prevent blindness).

Takayasu Arteritis

 Granulomatous inflammation of the aortic arch and its branches.


 Affects young women <40 years (“pulseless disease”).

 Clinical: Weak/absent pulses in upper limbs, fever, night sweats.

 Morphology similar to giant cell arteritis but in younger patients.

 Complications: Stenosis, aneurysm.

Medium Vessel Vasculitis

Polyarteritis Nodosa (PAN)

 Necrotizing vasculitis of medium-sized muscular arteries.

 Often renal and visceral arteries involved; spares pulmonary arteries.

 Usually in middle-aged adults.

 Associated with HBV infection in ~30% cases.

 Clinical: Hypertension, abdominal pain, renal infarcts, skin nodules.

 Morphology: Segmental transmural necrotizing inflammation → aneurysms and


thrombosis → ischemia.

 Treatment: Corticosteroids + immunosuppressants.

Kawasaki Disease

 Acute febrile illness of infants/young children.

 Medium vessel vasculitis involving coronary arteries.

 Clinical: Fever, conjunctivitis, mucosal erythema, lymphadenopathy, rash.

 Major concern: Coronary artery aneurysms → thrombosis or rupture.

 Treatment: IVIG and aspirin.

Small Vessel Vasculitis

Microscopic Polyangiitis

 Necrotizing vasculitis affecting capillaries, arterioles, venules.


 c-ANCA negative, p-ANCA positive.

 Clinical: Pulmonary hemorrhage, rapidly progressive glomerulonephritis.

 No granulomas.

Granulomatosis with Polyangiitis (GPA, Wegener)

 Necrotizing granulomatous inflammation of respiratory tract + necrotizing vasculitis


of small vessels.

 c-ANCA positive (anti-PR3).

 Clinical triad:

o Upper respiratory tract: sinusitis, nasal ulceration

o Lower respiratory tract: lung nodules/cavities

o Renal: pauci-immune glomerulonephritis

 Morphology: Granulomas with necrosis and vasculitis.

Churg-Strauss Syndrome (Eosinophilic Granulomatosis with Polyangiitis)

 Necrotizing granulomatous vasculitis with eosinophilia.

 Asthma, allergic rhinitis common.

 p-ANCA positive in ~40%.

 Clinical: Asthma, peripheral eosinophilia, vasculitis.

Thromboangiitis Obliterans (Buerger Disease)

 Segmental, thrombosing inflammation of small and medium arteries, mainly in young


male smokers.

 Clinical: Claudication, ulceration, gangrene of fingers/toes.

 Pathology: Highly cellular inflammatory thrombus with sparing of vessel wall.

Vasculitis Associated With Other Noninfectious Disorders

 Systemic lupus erythematosus (SLE) vasculitis: Immune complex deposition in


vessels.
 Rheumatoid vasculitis: Medium and small vessel involvement.

 Henoch-Schönlein purpura: IgA immune complex vasculitis, often pediatric.

 Others: Cryoglobulinemic vasculitis, Behçet disease.

Infectious Vasculitis

 Due to direct invasion of vessel wall by bacteria, fungi, viruses.

 Examples:

o Mycotic aneurysms (infected arterial aneurysms)

o Septic emboli causing vascular thrombosis and infarcts

o Syphilitic aortitis (tertiary syphilis)

Absolutely! Here are ultra-detailed, topper-style notes on Disorders of Blood Vessel


Hyperreactivity from Robbins & Cotran 10th edition, pages 516-517:

Disorders of Blood Vessel Hyperreactivity

Functional abnormalities of vascular tone causing intermittent vasospasm and ischemia

Raynaud Phenomenon

Definition:
A paroxysmal vasospasm of small arteries and arterioles, especially in fingers and toes,
triggered by cold or emotional stress, leading to color changes in the skin.

Types

Type Description Clinical Features

Primary Raynaud Idiopathic, usually young Symmetric attacks; triphasic color


Phenomenon women changes:

 White (ischemia)

 Blue (deoxygenation)
 Red (reperfusion) |
| Secondary Raynaud Phenomenon | Due to an underlying disease | More severe;
asymmetric; may lead to ulcers or gangrene; associated with:

 Systemic sclerosis

 SLE

 Buerger disease

 Atherosclerosis |

Pathogenesis

 Exaggerated vasoconstriction mediated by α2-adrenergic receptors on vascular


smooth muscle

 Structural vascular abnormalities in secondary form (intimal thickening, fibrosis)

Morphology

 Usually normal vessel histology in primary form

 Secondary: fibrosis, lumen narrowing, thrombosis in small arteries

Clinical Manifestations

 Episodic pallor, cyanosis, and rubor of digits

 Numbness, pain during attacks

 Chronic cases: skin atrophy, ulceration

Myocardial Vessel Vasospasm

Also known as: Prinzmetal angina or variant angina

Definition

Transient spasm of the coronary arteries causing myocardial ischemia without fixed
atherosclerotic obstruction.
Pathogenesis

 Hyperreactivity of vascular smooth muscle → intense vasospasm

 Endothelial dysfunction may play a role

Clinical Features

 Episodes of chest pain at rest

 Transient ST-segment elevation on ECG during pain

 Symptoms relieved by nitrates or calcium channel blockers

Morphology

 No permanent damage in pure vasospasm

 Can cause myocardial infarction if prolonged

Importance in Clinical Practice

 Differentiates from typical exertional angina caused by fixed obstruction

 Treatment focuses on relieving vasospasm

VEINS AND LYMPHATICS

Structure, function, and pathology of veins and lymphatic vessels

Varicose Veins

Definition

Dilated, tortuous superficial veins caused by increased intraluminal pressure and valve
incompetence.

Etiology and Risk Factors

 Prolonged standing or increased intra-abdominal pressure (pregnancy, obesity)

 Familial predisposition
 Age and female sex

Pathogenesis

 Valve incompetence → venous reflux

 Venous dilation → wall remodeling and further valve damage

 Venous hypertension → vein wall thickening and varicosities

Common Sites

 Superficial veins of lower extremities (great and small saphenous veins)

 Esophageal varices (due to portal hypertension)

 Hemorrhoids (anal canal veins)

Morphology

 Dilated, elongated, and tortuous veins with thickened walls

 Intimal fibrosis

 Sometimes thrombosis and inflammation (superficial thrombophlebitis)

Clinical Features

 Aching pain, swelling, fatigue in affected limbs

 Risk of thrombophlebitis and skin ulceration

Thrombophlebitis and Phlebothrombosis

Definitions

 Thrombophlebitis: Inflammation of a vein with associated thrombosis, usually in


superficial veins

 Phlebothrombosis: Thrombosis without obvious inflammation, usually in deep veins

Etiology
 Stasis of blood flow

 Endothelial injury

 Hypercoagulability (Virchow’s triad)

Sites

 Deep leg veins (deep vein thrombosis, DVT) are clinically important because of risk of
embolism.

Complications

 Pulmonary embolism (from DVT)

 Post-thrombotic syndrome (chronic venous insufficiency)

 Local inflammation and pain

Superior and Inferior Vena Caval Syndromes

Superior Vena Caval (SVC) Syndrome

 Obstruction of SVC → venous congestion of head, neck, and upper limbs

 Causes: Lung cancer (esp. small cell), lymphoma, thrombosis from catheters

 Clinical: Facial swelling, plethora, cyanosis, distended veins

Inferior Vena Caval (IVC) Syndrome

 Obstruction of IVC → lower limb edema, venous collaterals on abdomen

 Causes: Tumors, thrombosis

Lymphangitis and Lymphedema

Lymphangitis

 Acute inflammation of lymphatic vessels

 Usually bacterial infection (Group A Streptococcus) spreading from skin wound

 Clinical: Red streaks along lymphatic vessels, fever, chills


Lymphedema

 Chronic swelling due to lymphatic obstruction or malformation

 Causes:

o Primary: Congenital hypoplasia or aplasia of lymphatics

o Secondary: Surgery, radiation, infection (filariasis), tumors

 Morphology: Interstitial fluid accumulation with fibrosis and chronic inflammation

 Clinical: Non-pitting edema, skin thickening (“elephantiasis” in filariasis)

VASCULAR TUMORS

Neoplasms derived from blood vessels or lymphatics with a spectrum from benign to
malignant

Benign Tumors and Tumor-Like Conditions

1. Hemangiomas

 Definition: Benign tumors of blood vessel endothelial cells.

 Types:

o Capillary hemangioma: Most common; small, closely packed capillaries; often


in skin, mucous membranes; “strawberry” hemangioma in infants.

o Cavernous hemangioma: Large dilated vascular channels; may involve deeper


structures like liver, brain.

 Clinical: Usually present at birth or early childhood; may regress spontaneously.

 Morphology: Lobulated mass of vascular channels lined by flattened endothelium,


with minimal atypia.

2. Lymphangiomas

 Benign tumors of lymphatic vessels.

 Types:

o Simple (capillary) lymphangioma: Small lymphatic channels.

o Cystic hygroma: Large cystic lymphatic spaces; often in neck region.

 Associated with: Turner syndrome, Down syndrome.


 Morphology: Thin-walled lymphatic channels lined by endothelium, often filled with
proteinaceous fluid.

3. Glomus Tumor

 Tumor of modified smooth muscle cells of the glomus body.

 Common under fingernails; painful.

 Well-circumscribed, reddish-blue nodule.

4. Reactive Vascular Proliferations

 Pyogenic granuloma (Lobular capillary hemangioma): Rapidly growing red polypoid


lesion, often after trauma.

 Not true neoplasms but reactive proliferation.

Intermediate-Grade (Borderline) Tumors

1. Kaposiform Hemangioendothelioma

 Occurs in infancy and childhood.

 Locally aggressive but no metastasis.

 Histology: Nodules of spindle cells with slit-like vascular spaces.

2. Epithelioid Hemangioendothelioma

 Low-grade malignant vascular tumor.

 Occurs in soft tissue, liver, lungs.

 Histology: Epithelioid endothelial cells in myxohyaline stroma.

 Clinical course is variable, often indolent.

Malignant Tumors

1. Angiosarcoma

 Malignant endothelial cell tumor.

 Occurs in skin, soft tissues, breast (post-radiation), liver (especially with vinyl chloride
exposure).

 Highly aggressive with early metastasis.

 Morphology:
o Poorly formed vascular channels or solid sheets of malignant endothelial
cells.

o Cells show marked atypia, mitoses, and multilayering.

 Clinical: Rapidly enlarging, infiltrative mass, often ulcerated.

2. Kaposi Sarcoma

 Vascular tumor associated with HHV-8 infection.

 Types:

o Classic: Mediterranean elderly men, indolent.

o Endemic (African): More aggressive.

o AIDS-associated (epidemic): Aggressive, widespread.

o Iatrogenic (transplant-related).

 Pathogenesis: HHV-8 latent infection causes proliferation of spindle endothelial cells.

 Morphology:

o Early: Patch and plaque stages with thin, jagged vascular channels.

o Nodular stage: Spindle cell proliferation, slit-like vascular spaces, extravasated


RBCs, hemosiderin.

 Clinical: Purple macules/nodules on skin; can involve mucosa, lymph nodes, viscera.

PATHOLOGY OF VASCULAR INTERVENTION

Endovascular Stenting

Definition

Placement of a metal mesh (stent) into a blood vessel to restore patency in stenotic or
occluded arteries, commonly used in coronary and peripheral arteries.

Indications

 Atherosclerotic arterial stenosis (e.g., coronary artery disease)

 Restenosis after angioplasty

 Dissection or aneurysms needing reinforcement


Pathologic Changes Post-Stenting

1. Intimal Hyperplasia

 Proliferation of smooth muscle cells and extracellular matrix deposition in the intima
as a healing response.

 May lead to in-stent restenosis (re-narrowing).

2. Inflammation

 Foreign body reaction to stent material.

 Chronic inflammatory infiltrate can promote neointimal proliferation.

3. Endothelialization

 Healing involves regrowth of endothelium over stent struts to reduce thrombosis


risk.

4. Thrombosis

 Early or late stent thrombosis may occur if endothelialization is incomplete or


platelet activation occurs.

Vascular Replacement

Definition

Surgical replacement of diseased vascular segments with grafts—autologous vein grafts or


synthetic prostheses (e.g., Dacron, PTFE).

Pathologic Considerations

1. Graft Patency

 Dependent on graft type, location, and host factors.

2. Vein Graft Disease

 Intimal hyperplasia and atherosclerosis can cause graft failure over time.

3. Synthetic Graft Complications

 Thrombosis, infection, anastomotic aneurysm formation.

4. Healing and Remodeling


 Endothelialization and incorporation into host tissue critical for long-term success.

Complications

 Infection of prosthetic grafts → sepsis, graft failure.

 Anastomotic intimal hyperplasia → stenosis.

 Pseudoaneurysm formation at anastomosis.

You might also like